Selected research
Industry Growth & Trends
Global Liranaftate Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Liranaftate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Liranaftate market include Zenyaku Kogyo Company, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Nanjing Changao Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd, Yangzijiang Pharmaceutical Group Co. Ltd and Zhejiang Wansheng Pharmaceutical Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Liranaftate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Liranaftate market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liranaftate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liranaftate.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Liranaftate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Liranaftate Market by Company
Zenyaku Kogyo Company
Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
Nanjing Changao Pharmaceutical Co. Ltd
Tianfang Pharmaceutical Co., Ltd
Yangzijiang Pharmaceutical Group Co. Ltd
Zhejiang Wansheng Pharmaceutical Co. Ltd
Liranaftate Segment by Type
Cream
Spray
Liranaftate Segment by Application
Tinea Pedis
Jock Itch
Liranaftate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liranaftate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liranaftate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liranaftate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Liranaftate companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cream
- Spray
Applications
- Tinea Pedis
- Jock Itch
Companies covered
- Zenyaku Kogyo Company
- Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
- Nanjing Changao Pharmaceutical Co. Ltd
- Tianfang Pharmaceutical Co., Ltd
- Yangzijiang Pharmaceutical Group Co. Ltd
- Zhejiang Wansheng Pharmaceutical Co. Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Liranaftate Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Liranaftate Market Size by Region (2021-2032)
- 1.4.1 Global Liranaftate Market Size by Region (2021-2026)
- 1.4.2 Global Liranaftate Market Size by Region (2027-2032)
- 1.5 Key Regions Liranaftate Market Size (2021-2032)
- 1.5.1 North America Liranaftate Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Liranaftate Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Liranaftate Market Size Growth Rate (2021-2032)
- 1.5.4 South America Liranaftate Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Liranaftate Market Size Growth Rate (2021-2032)
2 Liranaftate Market by Type
- 2.1 Type Introduction
- 2.1.1 Cream
- 2.1.2 Spray
- 2.2 Global Liranaftate Market Size by Type
- 2.2.1 Global Liranaftate Market Size Overview by Type (2021-2032)
- 2.2.2 Global Liranaftate Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Liranaftate Market Size Forecasted by Type (2027-2032)
- 2.3 Global Liranaftate Market Size by Regions
- 2.3.1 North America Liranaftate Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Liranaftate Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Liranaftate Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Liranaftate Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Liranaftate Market Size Breakdown by Type (2021-2026)
3 Liranaftate Market by Application
- 3.1 Type Introduction
- 3.1.1 Tinea Pedis
- 3.1.2 Jock Itch
- 3.2 Global Liranaftate Market Size by Application
- 3.2.1 Global Liranaftate Market Size Overview by Application (2021-2032)
- 3.2.2 Global Liranaftate Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Liranaftate Market Size Forecasted by Application (2027-2032)
- 3.3 Global Liranaftate Market Size by Regions
- 3.3.1 North America Liranaftate Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Liranaftate Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Liranaftate Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Liranaftate Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Liranaftate Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Liranaftate Industry Trends
- 4.2 Liranaftate Industry Drivers
- 4.3 Liranaftate Industry Opportunities and Challenges
- 4.4 Liranaftate Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Liranaftate Revenue (2021-2026)
- 5.2 Global Liranaftate Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Liranaftate Key Company Headquarters & Area Served
- 5.4 Global Liranaftate Company, Product Type & Application
- 5.5 Global Liranaftate Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Liranaftate Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Liranaftate Players Market Share by Revenue in 2025
- 5.6.3 2025 Liranaftate Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Zenyaku Kogyo Company
- 6.1.1 Zenyaku Kogyo Company Company Information
- 6.1.2 Zenyaku Kogyo Company Business Overview
- 6.1.3 Zenyaku Kogyo Company Liranaftate Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Zenyaku Kogyo Company Liranaftate Product Portfolio
- 6.1.5 Zenyaku Kogyo Company Recent Developments
- 6.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
- 6.2.1 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Company Information
- 6.2.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Business Overview
- 6.2.3 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 6.2.5 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Recent Developments
- 6.3 Nanjing Changao Pharmaceutical Co. Ltd
- 6.3.1 Nanjing Changao Pharmaceutical Co. Ltd Company Information
- 6.3.2 Nanjing Changao Pharmaceutical Co. Ltd Business Overview
- 6.3.3 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 6.3.5 Nanjing Changao Pharmaceutical Co. Ltd Recent Developments
- 6.4 Tianfang Pharmaceutical Co., Ltd
- 6.4.1 Tianfang Pharmaceutical Co., Ltd Company Information
- 6.4.2 Tianfang Pharmaceutical Co., Ltd Business Overview
- 6.4.3 Tianfang Pharmaceutical Co., Ltd Liranaftate Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Tianfang Pharmaceutical Co., Ltd Liranaftate Product Portfolio
- 6.4.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
- 6.5 Yangzijiang Pharmaceutical Group Co. Ltd
- 6.5.1 Yangzijiang Pharmaceutical Group Co. Ltd Company Information
- 6.5.2 Yangzijiang Pharmaceutical Group Co. Ltd Business Overview
- 6.5.3 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Product Portfolio
- 6.5.5 Yangzijiang Pharmaceutical Group Co. Ltd Recent Developments
- 6.6 Zhejiang Wansheng Pharmaceutical Co. Ltd
- 6.6.1 Zhejiang Wansheng Pharmaceutical Co. Ltd Company Information
- 6.6.2 Zhejiang Wansheng Pharmaceutical Co. Ltd Business Overview
- 6.6.3 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 6.6.5 Zhejiang Wansheng Pharmaceutical Co. Ltd Recent Developments
7 North America
- 7.1 North America Liranaftate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Liranaftate Market Size by Country (2021-2026)
- 7.3 North America Liranaftate Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Liranaftate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Liranaftate Market Size by Country (2021-2026)
- 8.3 Europe Liranaftate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Liranaftate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Liranaftate Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Liranaftate Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Liranaftate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Liranaftate Market Size by Country (2021-2026)
- 10.3 South America Liranaftate Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Liranaftate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Liranaftate Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Liranaftate Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst